Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.

Jia (Jenny) Liu, Anna Rachel Minchom, Alastair Greystoke, T. R. Jeffry Evans, Debashis Sarker, Anthony M. Joshua, Cienne Morton, Burak Y. Aktas, Rasha Cosman, Dominika Chwialkowska, Jeremy Paull, Nicola Jane Main, Bernadette Marie Jean-Francois, Julia Le Meur, Stephanie Ruth Edmondson, Natalie Cook

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Number of pages1
JournalJournal of Clinical Oncology
Volume42
Issue number16 Supplement
Early online date29 May 2024
DOIs
Publication statusPublished - 1 Jun 2024

Cite this